Cetuximab trials for Non-Small-Cell Lung Cancer
All Cetuximab trials · All Non-Small-Cell Lung Cancer trials
7
Recruiting trials
Phase breakdown
Phase 1 7Phase 2 2
Recruiting trials studying Cetuximab for Non-Small-Cell Lung Cancer
- A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
- A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
- A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
- BBO-11818 in Adult Subjects With KRAS Mutant Cancer
- FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
- MOONRAY-01, A Study of LY3962673 in Participants With KRAS G12D-Mutant Solid Tumors
- Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Common questions
How many trials study Cetuximab for Non-Small-Cell Lung Cancer?
7 recruiting trials.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.